글로벌 의료기기 코팅 시장 – 2024-2031년

Overview
The global medical device coatings market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
The global medical device coatings market is a complex process that requires an adequate working environment (to prevent uneven coatings and chances of flaking), stringent coating protocols (to comply with the established regulatory standards), a trained workforce (to handle the coating equipment satisfactorily), and expensive infrastructure.
Driven by the growing demand for medical devices and unique coating requirements for each type of medical device, an increasing number of medical device companies are leveraging the superior technical expertise and experience of medical coating companies.
MDCs prevent surfaces of several medical devices, such as dentistry, neurology, and others. Their use results in proper sanitation, corrosion resistance, and biocompatibility. Their use reduces thrombogenicity, allergic reactions, and trauma to blood vessels.
Medical device coating adds a hard surface that protects the devices from abrasion, chipping, or scratching. For decoration and marking, medical coating manufacturers use their techniques to add markers on their devices to ensure that defective devices can be isolated and traced back to the source.
They help maintain sharp edges on cutting instruments while improving wear resistance, reducing galling between sliding components, and increasing lubricity. They also assist in avoiding allergenic substances while resisting bacteria on medical devices, which can be used on several patients without risking new infections.
Market Dynamics: Drivers
Technological Advancements in Coating Technologies
The demand for the medical device coatings market is driven by multiple factors. Advanced coating techniques like magnetron sputtering and plasma-enhanced chemical vapor deposition (PECVD) offer significant advantages for medical devices by improving corrosion resistance, durability, and biocompatibility. These coatings enhance device performance and patient safety, with applications in implants, wearables, and diagnostic tools.
Advancements in technology have led to the development of new medical devices that require coatings. Key player strategies such as agreements help to drive the market. For instance, in August 2023, Asep Medical Holdings Inc. announced that it finished the final milestone in its acquisition of SafeCoat Medical Inc. and entered into an exclusive worldwide license agreement with the University of British Columbia through its subsidiary SafeCoat to develop and commercialize medical device coating technology.
This new technology is forwarded through SafeCoat Medical and the exclusive worldwide license from UBC. This transaction is anticipated to create significant new market opportunities that tackle the problem of maintaining sterile surfaces on medical devices and implants.
Technological progress is accelerating, and it can anticipate coatings that are even more responsive to medical needs. Imagine coatings that visibly show when a device is wearing out or even those that can modify their properties in real time based on the patient’s unique requirements.
For instance, in March 2022, DSM Biomedical and Svelte Medical Systems worked together to develop DISCREET Bioresorbable Coating Technology, which is employed with the SLENDER IDS and DIRECT RX Bioresorbable Coated Drug-Eluting Stent (DES) Systems.
Although only ICUs have 15%–20% of all hospital beds, they are the site of 50% of all instances of pneumonia and life-threatening bloodstream infections acquired in hospitals. Approximately 25% of hospitalized patients are susceptible to illnesses related to their care. Therefore, innovative techniques, proper cleaning, antibiotics, and disinfectants should be used to reduce the likelihood of high-risk HAIs arising during medical operations or when utilizing medical devices. Coating technology introduction is one such key technique.
Furthermore, innovations in biomaterials are also encouraging the creation of biocompatible coatings, which lower the possibility of negative reactions and encourage a smooth integration with the human body.
For instance, in March 2023 Biocoat Incorporated, a manufacturer of hydrophilic biomaterial coatings, coating services, and coating apparatus for medical devices, announced that its HYDAK UV coating is now being applied to two medical devices that have been granted FDA 510(k) clearance.
Restraints
Factors such as stringent regulatory compliance, and the rising cost of raw materials, limited durability & longevity, biocompatibility & safety concerns, and complexity of application, are expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The medical device coatings market is segmented based on product, coating type, application, material, chemistry, end-user, and region.
The segment antimicrobial coatings accounted for approximately 45.3% of the medical device coatings market share
The antimicrobial coatings segment is expected to hold the largest market share over the forecast period. This segment is attributed to their lower price and higher compatibility with different device materials, such as composite materials, carbon fiber, metal, stainless steel, and plastic. The segment is predicted to grow as a result of the rising R&D efforts and increasing implantable device usage.
The product demand would also be driven by its benefits, such as reduced friction, optical clarity, improved durability & lubricity, and the ability to withstand maintenance procedures including sterilization, storage, and cleaning.
For instance, in April 2022 BioInteractions, a biomaterials technology firm based in the United Kingdom, introduced TridAnt, a revolutionary coating technology for medical devices that represents a paradigm shift in the prevention of infection and protection against a wide range of pathogens. TridAnt focuses on developing the best bioengineering technique to bond the antimicrobial coating securely to the material of the different medical devices for their lifecycle.
A rise in the cases of chronic diseases and infectious diseases requiring hospitalizations and surgical procedures, along with an aging global population will be some factors driving the market growth for coated medical devices.
In addition, China-based CEMMA Medical Company Limited and Netherlands-based LipoCoat BV are co-developing a coated central venous catheter (CVC) to prevent HAIs caused by catheter bacterial contamination.
Moreover, various coating technologies in this market help to drive this segment's growth. For instance, in September 2021, Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets announced a merger with N2 Biomedical, a Bedford, MA-based company.
Also, in July 2021, Researchers at the Korea Institute of Science and Technology (KIST) built a human implantable medical device coating technology, which can boost the life span and stability of the medical device.
Geographical Analysis
North America accounted for approximately 41.2% of the medical device coatings market share
North America region is expected to hold the largest market share over the forecast period. Owing to the major players in this region well-organized medical services infrastructure and investments in healthcare spending, R& D facilities, and various range of healthcare services propel the market growth in this region. With healthcare costs on the rise, the area will probably need a lot more medical coating.
Major industry players in this field also approve products, which drives the market's growth. For instance, in June 2023, Surmodics stated that the SurVeil drug-coated balloon (DCB) would be utilized to treat patients with peripheral artery disease starting after receiving approval from the FDA.
Additionally, Concept Medical announced that the FDA had authorized their sirolimus-coated balloon Magic Touch PTA as an experimental device exemption (IDE) for superficial femoral arteries in May 2023.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the medical device coatings market. Owing to the lockdown endorsement placed by governments to contain COVID-19 spreading. The medical device coatings market includes major (Tier I and II) manufacturers such as DSM, Hydromer, Biocoat, and AST Products.
These suppliers have their manufacturing facilities spread across various countries. Similarly, the European Commission has recently approved revised harmonized standards to expedite the production of medical face masks, gloves, and sterilization devices & disinfectants, and alter particular requirements for emergency and transport ventilators.
Furthermore, the rising penetration of e-commerce platforms is projected to boost the sales of Medical Device Coatings over the coming years.
Market Segmentation
By Product
• Catheters
• Implants
• Electrosurgical Instruments
• Stents
• Others
By Coating Type
• Hydrophilic Coatings
• Antimicrobial Coatings
• Drug-eluting Coatings
• Anti-thrombogenic Coatings
• Others
By Application
• Neurology
• Orthopedics
• General surgery
• Cardiovascular
• Dentistry
• Gynecology
• Others
By Materials
• Polymers
• Metals
• Ceramics
• Others
By Chemistry
• Fluoropolymers
• Parylene
• Silicone
• Others
By End-User
• Academic Institutes
• Hospitals
• Research & Medical Device Companies
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the medical device coatings market include Surmodics, Inc., Sono-Tek Corporation, Hydromer, DSM, Biocoat Incorporated, TUA Systems, Harland Medical Systems, Inc, BioInteractions, Specialty Coating Systems Inc., ENDURA COATINGS PRIVATE LIMITED among others.
Key Developments
 On May 25, 2023, Bio-Gate AG, an innovative technology and individual solution provider, will launch its innovative HyProtect coating into new markets alongside its long-term partner OSSIS Ltd. It will be introduced into new markets by OSSIS Ltd., a New Zealand company. As part of the collaboration, orthopedic revision implants are primarily used to provide compassionate care for single patients in human medicine.
 On November 2, 2022, GTCR made a strategic investment in Biocoat Corporation, a specialty maker of hydrophilic biomaterial coatings, solutions, and dip-coating instruments for medical devices.
 On April 6, 2022, Biocoat Inc., a manufacturer of hydrophilic biomaterials coatings and coating equipment for medical devices, announced its expansion into hydrophilic dip coatings. The company is set to design, develop, and deliver the dip coating technology to coat medical devices. mental breakthrough in infection prevention and pathogen protection.
 On April 13, 2022, Harland Medical Systems, Inc. announced the release of the CTS1100 Coating Thickness Testing System at MD&M West.
Why Purchase the Report?
• To visualize the medical device coatings market segmentation based on product, coating type, application, material, chemistry, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of medical device coatings market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The medical device coatings market report would provide approximately 48 tables, 52 figures, and 182 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies